Neuromuscular

Clinical Research

fact_group

If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@ucdenver.edu for more information.

 

COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
18-1768Genomic Translation for Amyotrophic Lateral Sclerosis Care (GTAC)Laura Foster, MDClinical TrialsN/A
18-2341A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults with Generalized Myasthenia GravisDianna Quan, MDClinical TrialsN/A
18-2537Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others (INC-6601)Vera Fridman, MDClinical TrialsN/A
19-0772A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients with Generalized Myasthenia GravisStacy Dixon, MDClinical TrialsN/A
08-0623Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR AmyloidosisDianna Quan, MDClinical TrialsN/A
17-1132Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic StudyMatthew Wicklund, MDN/AN/A